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Introduction
The Joint Interim Statement (JIS) classification of 
metabolic syndrome is the most recent definition 
thereof, but nevertheless requires further refinement 
in terms of defining waist circumference (WC) 
measurement in this regard for sub-Saharan Africans.1 
Various studies have been conducted to define WC in 
sub-Saharan black Africans as a marker of metabolic 
syndrome.2-5 However, limited studies define WC in 
Caucasians from sub-Saharan Africa as an identifier of 
metabolic syndrome. The Europid WC cut-off points, 
of 94 cm for men and 80 cm for women, are the 
only WC measurements that are applicable to sub-
Saharan Caucasians, as stated within the JIS and by 
the International Diabetes Federation.1,6 According to 
the JIS, ethnic-specific WC cut-off points need to be 
developed. Therefore, it is necessary to determine 
whether or not the suggested European WC cut-off 
points are applicable to sub-Saharan Caucasians. 
With regard to two populations with a similar genetic 
background, but residing in different areas, findings 
revealed that environmental factors may have 
affected anthropometry.7 Seidell et al8 added that it 
is pertinent to develop different WC cut-off points for 
persons of specific descent and persons of the same 
descent living in other countries. Therefore, the use of 
European cut-off points for Caucasians from Africa 
may not be appropriate in determining metabolic 
syndrome prevalence, and to our knowledge, only one 
other study has investigated the WC cut-off point for 
sub-Saharan Caucasians (WC cut-off points of 97 cm 
for men and 84 cm for women).4
In order to further enrich the use of anthropometry as 
a screening tool for metabolic syndrome, neck cir-
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Abstract
Objectives: Waist circumference (WC) cut-off points specific to sub-Saharan Caucasians do not exist with which 
to identify metabolic syndrome. Neck circumference (NC), as an additional measure, was previously found to be 
a worthy identifier of metabolic syndrome. Therefore, the aim was to determine NC and WC cut-off points specific 
to our Caucasian cohort, to confirm baseline cut-off points and to determine whether or not WC cut-off points 
specific to this cohort differed from the Joint Interim Statement (JIS) WC guidelines. 
Design, subjects and setting: A target population study, nested in a prospective cohort, was assessed and included 
90 and 96 Caucasian men and women aged 24-65 years from the Dr Kenneth Kaunda Municipality District, North 
West province. 
Outcomes measures: Anthropometric and fasting biological markers for metabolic syndrome, e.g. systolic and 
diastolic blood pressure, glucose, triglycerides and high-density lipoprotein, were obtained. 
Results: Cut-off points were determined with the use of a receiver operating characteristic. With the use of cohort-
specific WC cut-offs, metabolic syndrome prevalence did not change. WC cut-off points were 96 cm for men and 
88 cm for women. NC cut-off points were 42 cm and 35 cm, for men and women, respectively. 
Conclusion: WC cut-off points specific to these Caucasians differed to those from the JIS guidelines, but 
corresponded with the baseline findings of the prospective cohort. From a clinical perspective, we cautiously 
suggest the application of NC, rather than WC, as an anthropometric measure of metabolic syndrome in women 
as it was a stronger predictor of metabolic syndrome and is not influenced by menopausal status per se. 
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cumference (NC) cut-off points were also determined. 
The literature has revealed that NC can be an identi-
fying measure of health risk,9-10 and that it is a worthy 
identifier of the presence of metabolic syndrome in 
sub-Saharan Caucasians.11
Findings from the prospective phase of the present 
Sympathetic Activity and Ambulatory Blood Pressure 
Study in Africans (SABPA) study suggest that WC cut-
off points should be further investigated in sub-Saharan 
Caucasians, and not just in Africans, as various studies 
have already investigated the latter.2-5 WC cut-off points 
from the current substudy suggest that the European 
reference values in metabolic syndrome might not be 
applicable to this specific Caucasian cohort; especially 
to the women. However, even with substitution of the 
WC defined by the JIS with the new cohort-specific WC 
for metabolic syndrome, the prevalence of metabolic 
syndrome remained similar.
To our knowledge, WC and NC cut-off points specific 
to metabolic syndrome for sub-Saharan Caucasians 
have only been investigated by the SABPA cohort.4-11 
Now, at three-year follow-up, it is necessary to confirm 
these cut-off points and to determine whether or not 
the cohort-specific anthropometric cut-off points differ 
from the European reference values (JIS), and hereby 




As this was a three-year follow-up, only participants 
from Phase I (2009) were included, which accounted 
for a successful follow-up rate of 89%. Exclusion 
criteria included pregnancy, lactation, a tympanum 
temperature > 37.5°C, and the use of alpha and 
beta blockers and psychotropic substance abuse. 
Blood donors and persons vaccinated in the three 
months prior to participation were also excluded. The 
2012 eligible participants (n = 186) were Caucasian 
teachers aged 24-65 years, and comprised 90 men 
and 96 women working in the Dr Kenneth Kaunda 
District Municipality in North West province, and thus 
was homogenous with regard to socio-economic class. 
Participants were fully informed of the procedure, and 
signed an informed consent form. The study conformed 
to the ethical principles for medical research involving 
human subjects of the World Medical Association 
Declaration of Helsinki (revised 2008) and was 
approved by the Ethics Review Board of North-West 
University, Potchefstroom Campus (NWU-00036-07S6). 
Procedure
Clinical assessments were performed from late summer 
until late autumn in 2012 over a two-day period for 
each participant, as described eslewhere.12 At 15h00 
each day of the working week, four participants were 
received at North-West University and stayed overnight 
at the Lipid Clinic and Metabolic Unit research facility 
on campus. They were introduced to the experimental 
set-up in order to lessen anticipation stress. Participants 
received standardised meals for the duration of data 
collection and were encouraged to go to bed at 22h00, 
after which they had to fast until the clinical measures 
were completed the next morning. Measurements 
commenced the next morning at 07h00, starting 
with the anthropometric measurements, which were 
followed by blood pressure and blood sampling. 
Lastly, in order to assess physical activity, participants 
were fitted with an Actiheart® Physical Activity Monitor 
(CamNtech, Cambridge, UK), to be worn over a seven-
day period. The epoch was set at 60-second intervals.
Anthropometric measurements
A level 2-accredited anthropometrist recorded the 
measures in triplicate. Maximum height was measured 
with a stadiometer to the nearest 0.1 cm, and weight 
was measured with weight evenly distributed on a 
Krups® scale to the nearest 0.1 kg. Height and weight 
was used to calculate body mass index (BMI) (kg/m2). 
Circumferences were taken with a non-extensible 
and flexible anthropometric tape, using standardised 
procedures. WC was taken at the midpoint between 
the lower costal rib and the iliac crest, perpendicular 
to the long axis of the trunk, and not at the narrowest 
point, for standardisation purposes. The NC was taken 
superior to the thyroid cartilage, perpendicular to 
the long axis of the neck.13 Inter- and intraobserver 
variability was less than 10%.
Clinical measurements
Participants were in a semi-recumbent position for 20-
30 minutes prior to the blood pressure measurements 
being taken with a calibrated sphygmomanometer 
using the Riva-Rocci-Korotkoff method on the non-
dominant arm14 by applying a suitable cuff. Two 
duplicate measures were taken, with a 3- to 5-minute 
resting period between each; the second of which was 
used for statistical analyses.
A registered nurse obtained fasting resting blood 
samples with a winged infusion set from the brachial 
vein branches of the dominant arm. Sodium fluoride 
glucose and serum samples for metabolic syndrome 
markers were handled according to standardised 
procedures and stored at -80°C. Analysis was 
performed using the Konelab™ 20i Sequential Multiple 
Analyzer Computer (ThermoScientific, Vantaa, Finland) 
and the timed, end-point method (UniCel® DxC 800, 
Beckman and Coulter, Germany) at independent 
accredited laboratories.
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Metabolic syndrome classifications 
Metabolic syndrome is defined as the presence of 
three or more of the following risk factors: 
• Triglycerides ≥ 1.7 mmol/l.
• High-density lipoprotein (HDL) of 1 mmol/l for men 
and < 1.3 mmol/l for women.
• Glucose ≥ 5.6 mmol/l.
• Systolic blood pressure ≥ 130 mmHg and/or diastolic 
blood pressure ≥ 85 mmHg.
• WC for men ≥ 94 cm and for women ≥ 80 cm.1 
Since WC is the variable for which cut-off points are 
developed, it therefore cannot be included in this 
model. Therefore, WC was excluded as a metabolic 
syndrome component to predict the presence of any 
two or more of the metabolic syndrome components. 
The use of two or more components other than WC has 
been successfully demonstrated in other South African 
studies.2-3 In our study, after specific cut-off points were 
developed, those contained in the JIS definition were 
substituted with the new cohort-specific cut-off points 
to determine the prevalence of metabolic syndrome.
Statistical analysis 
Data were analysed with SPSS® version 21 for Windows®. 
Initially, gender-specific descriptive statistics mean, 
standard deviation and proportions 
were determined. Thereafter, 
nonparametric receiver operating 
characteristic (ROC) curves, 
together with the area under the 
curve (AUC) were computed 
and the optimal cut-off points 
obtained from the Youden index (J) 
maximum (sensitivity + specificity - 
1). ROC statistics were computed 
using continuous WC values and 
categorical values for metabolic 
syndrome (any two or more 
factors other than WC) in order to 
determine the optimal WC cut-
off points. ROC statistics were also 
used to determine NC (continuous 
values) cut-off points for metabolic 
syndrome (categorical values). The 
AUC had to be more than 0.5 and 
closer to 1, indicating accuracy 
and not random chance. Adjusting 
for covariates was not possible 
during computation of the ROC 
statistical analysis. The ROC-derived 
WC cut-off points were then used 
instead of those contained in the 
JIS criteria in order to determine 
the prevalence of metabolic 
syndrome (any three or more components). Lastly, 
in order to determine which metabolic syndrome risk 
factors contributed the most to metabolic syndrome 
prevalence, AUC values were determined for each 
of the metabolic syndrome components (continuous 
values) using ROC statistics with metabolic syndrome 
as a categorical value.
Results
According to the JIS criteria, the metabolic syndrome 
profile of these Caucasian men was vulnerable 
regarding their HDL, diastolic blood pressure and WC 
values (Table I). In comparison, as a group, the woman 
had fewer risk factors for metabolic syndrome, and 
their low HDL and high WC values indicated metabolic 
syndrome risk. Although the WC for both the men 
and women was above the JIS threshold, these WC 
values might not be applicable to our specific cohort. 
Therefore, ROC statistics were computed in order 
to determine the WC cut-off points specific to this 
Caucasian cohort. The ROC developed WC cut-off 
points (Figure 1) for men and women, which were 96 
cm [AUC 0.63, 95% confidence interval (CI): 0.52-0.75] 
and 88 cm (AUC 0.61, 95% CI: 0.47-0.76), respectively, 
while the suggested JIS cut-off points were set at 94 cm 
for men and 80 cm for women. 
Table I: The descriptive statistics of the Caucasian men and women1
Descriptive characteristics Men (n = 90) Women (n = 96)
Age (years) 49.24 ± 10.19 49.90 ± 9.62
Oestradiol levels (pg/ml) 14.32 ± 9.53 74.32 ± 70.04
Body mass index (kg/m2) 30.24 ± 5.14 27.41 ± 6.85
Physical activity (Kcal/hour) 1 660.04 ± 1 577.93 1 099.45 ± 615.53
Gamma-glutamyl transferase (U/l) 35.66 ± 39.77 19.01 ± 23.73
Self-reported smokers (n) (%) 14 (15.6) 9 (9.4%)
Neck circumference (cm) 42.70 ± 3.23 34.44 ± 2.95
Metabolic syndrome components
Glucose (mmol/l) 4.69 ± 1.28 4.19 ± 1.17
High-density lipoprotein (mmol/l) 0.85 ± 0.23 1.26 ± 0.37
Triglycerides (mmol/l) 1.42 ± 1.11 0.96 ± 0.55
SBP (mmHg) 128.47 ± 13.25 118.93 ± 11.40
DBP (mmHg) 87.69 ± 9.46 79.10 ± 8.02
Waist circumference (cm) 106.12 ± 106.12 87.03 ± 14.37
Increased blood pressure (either SBP ≥ 130 mmHg 
and/or DBP ≥ 85 mmHg)*
56 (62.2%) 30 (31.3%)
Medication use
Diabetic (clinically diagnosed), n (%) 7 (7.8) 3 (3.1)
Hypertension (clinically diagnosed), n (%) 22 (24.44) 15 (15.62)
Statins, n (%) 20 (22.22) 13 (13.54)
Hormone replacement therapy, n (%) 0 (0) 28 (29.17)
DBP: diastolic blood pressure, SBP: systolic blood pressure
Data indicated as mean ± standard deviation
*: According to the Joint Interim Statement
Original Research: Examining waist and neck circumferences as screening tools for metabolic syndrome 
109 2014 Volume 19 No 3JEMDSA
The area under the curve was 0.63 (95% confidence 
interval: 0.52-0.75) for the men and 0.61 (95% 
confidence interval: 0.47-0.76) for the women
Considering the cohort-specific WC cut-off, metabolic 
risk was suggested in men regarding their mean WC 
(106 cm), while women were just below the newly 
developed threshold, with a mean WC of 87 cm. To 
determine metabolic syndrome prevalence, we used 
both the JIS-recommended WC cut-offs, as well as the 
cohort-specific WC cut-off points. 
Using the cohort-specific WC cut-off points, one less 
man and three less women presented with metabolic 
syndrome compared to the prevalence when the JIS 
cut-off points were used (Table II). Thus, metabolic 
syndrome prevalence remained similar using either the 
JIS, or cohort-specific, WC cut-off points, regardless of 
the difference in WC cut-off points between the JIS (80 
cm) or the cohort-specific (88 cm) criteria, especially 
in women. The prevalence of high WC changed 
considerably when the new cohort-specific criteria 
were used in women, although metabolic syndrome 
prevalence remained nearly unchanged.
When using the JIS criteria, there was a 64% prevalence 
of the women having a high WC, but a prevalence of 
only 39% when using the WC cut-offs specific to this 
cohort. On further investigation, it was demonstrated 
that although 48% of the men and 30% of women had 
WC cut-off points above the cohort-specific WC, they 
did not present with metabolic syndrome. Only 33% and 
8% of the men and women, respectively, with a WC 
above the cohort-specific cut-off point presented with 
metabolic syndrome. Thus, it seems that the definition of 
WC did not greatly affect the prevalence of metabolic 
syndrome in this specific Caucasian cohort, and that 
underlying cardiometabolic risk factors, other than WC, 
may have affected metabolic syndrome prevalence.
In order to determine which risk factors were more prone 
to contribute to metabolic syndrome prevalence, 
the AUC values were determined for each of the 
components of metabolic syndrome. Table III shows 
The area under the curve was 0.63 (95% confidence interval: 0.52-0.75) for the men 
and 0.61 (95% confidence interval: 0.47-0.76) for the women
Figure 1: Receiver operating characteristic curves depicting the 
waist circumference cut-off points for metabolic syndrome in 
Caucasian men and women
Table II: The prevalence of high waist circumference and metabolic syndrome
Men (n = 90) Women (n = 96)
JIS/IDF WC (94 cm) ROC WC (96 cm) JIS/IDF WC (80 cm) ROC WC (84 cm)
Metabolic syndrome prevalence, n (%) 31 (34.4) 30 (33.3) 12 (12.5) 9 (9.4)
High WC prevalence, n (%) 79 (87.8) 73 (81.1) 61 (63.5) 37 (38.5)
WC above the cut-off point, but no 
metabolic syndrome, n (%)
48 (53.3) 43 (47.8) 50 (52.1) 29 (30.2)
WC above the cut-off point and metabolic 
syndrome, n (%)
31 (34.4) 30 (33.3) 11 (11.5) 8 (8.3)
JIS/IDF: Joint Interim Statement/International Diabetes Federation, WC: waist circumference, ROC: receiver operating characteristic
Table III: The ranking of the metabolic syndrome risk factors according to area under the curve values
Men Women
Risk factor AUC (95% CI) Risk factor AUC (95% CI)
Systolic blood pressure 0.84 (0.75-0.92) Diastolic blood pressure 0.89 (0.82-0.96)
Diastolic blood pressure 0.78 (0.69-0.88) Systolic blood pressure 0.84 (0.75-0.93)
Triglycerides 0.73 (0.64-0.85) Glucose 0.83 (0.67-0.98)
Glucose 0.68 (0.56-0.81) Neck circumference 0.80 (0.65-0.96)
Waist circumference 0.68 (0.57-0.79) Waist circumference 0.77 (0.646-0.90)
Neck circumference 0.66 (0.54-0.78) Triglycerides 0.74 (0.55-0.93)
High-density lipoprotein 0.53 (0.38-0.68) High-density lipoprotein 0.48 (0.23-0.72)
AUC: area under the curve, CI: confidence interval
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the AUC results. The contributing factors are presenting 
in descending order, from the highest to the lowest.
According to the AUC values, WC was a low 
contributor to metabolic syndrome, for the both men 
and women. Because metabolic syndrome is defined 
as the presence of three risk factors, we evaluated 
the top three components according to their AUC 
values. Blood pressure contributed greatly to the 
development of metabolic syndrome in both the men 
and women. Triglycerides and glucose were the third 
highest contributing factor in the men and women, 
respectively. The finding that NC was ranked higher 
than WC with respect to women was of interest. This 
could indicate that NC is a superior measure to WC 
when determining metabolic syndrome in women, 
especially considering the great variability in the 
WC cut-off points for women. The NC cut-off points 
determined for metabolic syndrome were 42 cm (AUC 
0.66, 95% CI: 0.54-0.78) for men, and 35 cm (AUC 0.80, 
95% CI: 0.65-0.96) for women (Figure 2).
The area under the curve was 0.66 (95% confidence 
interval: 0.54-0.78) for the men and 0.80 (95% 
confidence interval: 0.65-0.96) for the women.
As hypertensive status contributed more to metabolic 
syndrome prevalence than WC, we determined 
what the prevalence of hypertension and high WC 
were when using the WC cut-off points for metabolic 
syndrome (Table IV). 53.3% of the men and 85.7% of 
the men with hypertension presented with a WC above 
the cohort-specific cut-off point, whereas 19.8% of the 
women and 63.3% of the women with hypertension 
also presented with an increased WC.
Discussion
We demonstrated that the WC cut-off specific to our 
Caucasian cohort varied from the suggested Europid 
(JIS) cut-off points and that these cohort-specific cut-
off points corresponded to the baseline findings.
Concerning the WC cut-off point for men, the cohort-
specific WC cut-off point of 96 cm was similar to the 
JIS WC cut-off point of 94 cm, whereas the women’s 
WC cut-off point of 88 cm varied greatly from the JIS 
cut-off point of 80 cm, in being a marker of metabolic 
syndrome. The same tendency, whereby men had a 
similar, and women a different, cut-off point than the 
JIS, was also found in black African men and women 
from the same area (WC cut-off point of 92 cm for 
men, and 94 cm for women).15 
Referring to the WC cut-off points developed in the 
same group at baseline (in 2009), the men had a 
similar WC cut-off point (97 cm in 2009 and 96 cm in 
2012), whereas there was a slight difference between 
the WC cut-off point of 84 cm at baseline4 and 88 cm 
at follow-up for the women. This increase in the cut-
off point may be ascribed to ageing or menopause, 
when women tend to develop a more android build, 
with an accompanying increase in visceral fat.16 This is 
supported by the mean oestradiol value of the total 
female group, which was well above 32.2 pg/ml.16 
Approximately 29% of the women used hormone 
replacement therapy which could have further 
increased the higher oestradiol, and subsequently the 
WC, values. 
When substituting the WC JIS cut-off points 
with the cohort-specific WC cut-off points 
in determining metabolic syndrome, it was 
assumed that metabolic syndrome prevalence 
would change or differ with the use of varying 
cut-off points. However, this was not the case. 
Metabolic syndrome prevalence was similar in 
both the men and women, regardless of which 
cut-off points were used. This could indicate 
that WC did not play a large role in determining 
metabolic syndrome outcome in the Caucasians 
in this cohort, and that other underlying 
cardiometabolic risk factors, other than WC, may 
have affected metabolic syndrome prevalence. 
The area under the curve was 0.66 (95% confidence interval: 0.54-0.78) for the men 
and 0.80 (95% confidence interval: 0.65-0.96) for the women
Figure 2: Receiver operating characteristic curves depicting the 
neck circumference cut-off points for metabolic syndrome in 
Caucasian men and women
Table IV: The prevalence of high waist circumference and hyptertension
Men (n = 90) Women (n = 96)
ROC WC (96 cm) ROC WC (84 cm)
Hypertension prevalence, n (%) 56 (62.2) 30 (31.3)
High WC prevalence, n (%) 73 (81.1) 37 (38.5)
WC above the cut-off point, but no 
hypertension, n (%)
25 (27.8) 18 (18.8)
WC above the cut-off point and 
hypertension, n (%)
48 (53.3) 19 (19.8)
WC above the cut-off point in 
hypertensive persons 
(men, n = 56; women, n = 30)
48 (85.7) 19 (63.3)
ROC: receiver operating characteristic, WC: waist circumference
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Furthermore, it was revealed that although women 
had a high WC (whether using the JIS- or the cohort-
specific cut-off points), they do not necessarily present 
with metabolic syndrome, which could possibly be 
explained by the fact that their mean WC was below 
that of the cohort-specific WC. 
Study highlights
Prevalence of metabolic syndrome prevalence did 
not change when we used the WC cut-off point that 
was specific to our cohort. Therefore, we wanted to 
determine which other factors affected metabolic 
syndrome prevalence more profoundly than WC. It 
was found that blood pressure affected metabolic 
syndrome prevalence the most in both the men 
and women in this cohort. Another finding from this 
study was that most men who had a high WC also 
presented with hypertension. Although blood pressure 
was the strongest contributor to metabolic syndrome 
prevalence in our study, more research is needed on 
sub-Saharan Caucasians with regard to blood pressure 
and hypertensive status. A general health survey of more 
than 59 000 individuals reported that hypertension was 
under-diagnosed, thereby increasing the significant 
burden of cardiovascular disease in South Africa.17 The 
prevalence of high blood pressure in the mentioned 
population seems to have been underestimated. 
During this survey, the weighted prevalence of self-
reported diagnosis of hypertension by a health 
professional was 10.4% in white South Africans, and the 
age-standardised rate was not significantly different by 
sex.17 In our group, hypertension was under-diagnosed 
as well (15-38%), which may implicate the risk of future 
cardiovascular events. A national registry is urgently 
needed to inform the medical community of the 
prevalence of hypertension, cardiovascular events 
and survival estimates. This may impact on the medical 
treatment regime for metabolic syndrome and the 
approach for future cardiometabolic research.
Even though WC did not greatly affect metabolic 
syndrome prevalence in this cohort, it is still necessary to 
develop cut-off points that are specific to a particular 
group. WC or NC can easily be incorporated in any 
primary healthcare procedure. Despite anthropometric 
measures that were above the cut-off points which did 
not necessarily reflect metabolic syndrome prevalence 
in this cohort, having a value above a certain cut-off 
point could prompt healthcare action, which, in turn, 
could help to improve health.8 Developing consistent 
WC values is a challenge in Caucasian women, 
although these women do not seem to be as vulnerable 
to metabolic syndrome as their male counterparts. 
According to recent findings, it seems as if NC might 
be valuable to consider as an additive or alternative 
measure with which to ascertain the presence of 
metabolic syndrome. Present findings indicate that NC 
is ranked higher than WC as a contributor to metabolic 
syndrome prevalence (Table III), mostly in women. Prior 
baseline findings (40 cm for young and 41 cm for older 
Caucasian men; 34 cm for young and 33 cm for older 
Caucasian women),11 were that the NC cut-off points 
for both the men and women remained similar to the 
present findings (42 cm for men and 35 cm for women). 
This finding could lead us to believe that over time, 
NC is more constant than WC in identifying metabolic 
syndrome prevalence, especially in women. It is 
already known that NC is an ideal measure because 
it does not change during the day or with menopausal 
status, as is the case with WC.9 Therefore, it would seem 
that NC was a valuable anthropometric screening tool 
for metabolic syndrome for the women in this cohort, 
which confirms the findings from baseline.11 
Indeed, increases in NC have been associated with 
cardiometabolic risk, as well as obstructive sleep 
apnoea (OSA).18,19 A NC greater than 40 cm in women 
and 42.5 cm in men correlates with an increased 
risk of OSA, whereas increasing NC correlates with 
increased severity of OSA.18 OSA, characterised by 
recurrent episodes of partial or complete upper airway 
obstruction during sleep, has been newly recognised 
as a secondary cause of hypertension. We evaluated 
OSA via the validated Berlin questionnaire,20 where 
the prevalence of OSA was evident in 30.65% of the 
Caucasian cohort. OSA triggers a cascade of adverse 
effects, including increased sympathetic activity, 
systemic inflammation and metabolic dysregulation 
that may contribute to poor blood pressure control.19 
The poor blood pressure control in our population 
exemplifies the importance of screening for OSA and 
NC to evaluate cardiometabolic function.
Strengths and limitations of the study
A strength of this study was the inclusion of a unique, 
homogenous group of urban Caucasians from North 
West province within a highly standardised experimental 
protocol. A further strength was that we contributed 
to novel data on ethnic-specific anthropometric 
cut-off points. The study was limited by the sample 
size as we could only include participants from the 
baseline study. Additionally, because of the specific 
characteristics of the participants (region, occupation 
and income), the results cannot be applied to other 
Caucasian populations in Africa. Therefore, larger 
sample sizes in more diverse groups should be assessed 
in order to obtain more valid and clinically applicable 
recommendations. 
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Conclusion
We conclude that cohort-specific WC cut-off points 
differ from the JIS cut-off points and that the WC and 
NC cut-off points from the present study strengthened 
the cut-off points from baseline, especially in men. We 
cautiously suggest that as an identifier of metabolic 
syndrome, the WC cut-off points should be 96 cm 
and 88 cm for the men and women, respectively, in 
this cohort. We also found that the NC cut-off points 
for metabolic syndrome were 41 cm and 35 cm for 
the men and women, respectively, in this Caucasian 
cohort. From a clinical perspective, we recommend 
applying NC, rather than WC, as an anthropometric 
measure of metabolic syndrome in women as it was a 
stronger predictor thereof, and may not be influenced 
by menopausal status per se. 
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